Pharmacological inhibition of USP7 has been achieved during the last decade, and multiple novel agents (HBX42108, HBX19818, HBX28258, P5091, and P22077) have been reported to inhibit USP7 in cancer cells [8,31,32,33,34]. This evidence concerns the gene USP7 and cancer.